Loading news...
Cerity Partners LLC grew its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 14.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 371,198 shares of the company's stock after purchasing an additional 46,137 shares during the quarter. Cerity Partners LLC owned
Stephanie Link, chief investment officer at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio moves.
Investors looking for stocks in the Medical - Drugs sector might want to consider either United Therapeutics (UTHR) or Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their buck right now?
Community Trust and Investment Co. raised its stake in shares of Zoetis Inc. (NYSE: ZTS) by 5.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 116,408 shares of the company's stock after buying an additional 6,014 shares during the quarter.
Chicago Capital LLC reduced its stake in Zoetis Inc. (NYSE: ZTS) by 92.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,721 shares of the company's stock after selling 226,129 shares during the period. Chicago Capital LLC's holdings in Zoetis were
Bank Pictet and Cie Europe AG boosted its position in shares of Zoetis Inc. (NYSE: ZTS) by 1.5% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 398,610 shares of the company's stock after purchasing an additional 6,050 shares during the quarter. Zoetis
Viking Therapeutics has important catalysts on the horizon. Zoetis looks well-positioned to overcome recent challenges.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 12, 2026. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2025 financial results and respond to questions from financial analysts. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-present.
Ethic Inc. decreased its position in Zoetis Inc. (NYSE: ZTS) by 28.9% during the undefined quarter, according to the company in its most recent filing with the SEC. The fund owned 37,851 shares of the company's stock after selling 15,402 shares during the quarter. Ethic Inc.'s holdings in Zoetis were worth $5,538,000 at
Carnegie Investment Counsel lifted its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 6.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 340,532 shares of the company's stock after purchasing an additional 21,563 shares during
Pet spending stayed resilient in 2025 despite inflation. See which pet care stocks Wall Street is watching heading into 2026.
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to explain why she's buying more Zoetis.
Zoetis (ZTS) closed at $123.78 in the latest trading session, marking a +1.26% move from the prior day.
CHICAGO TRUST Co NA decreased its stake in shares of Zoetis Inc. (NYSE: ZTS) by 43.8% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,176 shares of the company's stock after selling 4,818 shares during the quarter. CHICAGO TRUST Co
Figma, Pinterest, and Zoetis are struggling this year due to a combination of high valuations and disappointing earnings. However, they possess some attractive long-term growth opportunities.
Addenda Capital Inc. bought a new position in shares of Zoetis Inc. (NYSE: ZTS) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 29,372 shares of the company's stock, valued at approximately $4,298,000. Several other institutional investors and hedge funds have also
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026. Kristin Peck, Chief Executive Officer, and Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 10:30 a.m. PT. Investors and other interested parties can access a live audio webcast of the presentation by visiting https://investor.zoetis.com/events-present.
One is a sector mainstay that has now raised its payout 17 years in a row. The other is a big player in the animal healthcare space.
CNP, VAC, PCG and ZTS raised dividends as tech volatility and economic uncertainty push income-focused investors toward steadier stocks.
B. Riley Wealth Advisors Inc. bought a new stake in Zoetis Inc. (NYSE: ZTS) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 7,586 shares of the company's stock, valued at approximately $1,183,000. Several other institutional investors and hedge funds have